Minerva Neurosciences
develops and commercializes clinical-stage products for the treatment of central nervous system diseases... Read moreMinerva Neurosciences
develops and commercializes clinical-stage products for the treatment of central nervous system diseases... Read more
News
Feb 25, 2025
FinanzNachrichten
Minerva Neurosciences: Minerva Neurosciences, Inc: Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Business Updates
Feb 25, 2025
Marketscreener
Minerva Neurosciences: Minerva Neurosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024
Feb 25, 2025
Owler
Minerva Neurosciences, Inc.: Minerva Neurosciences's employee count changed from 9 in Dec 2023 to 8 in Dec 2024
May 01, 2024
GlobeNewswire
Press Release: Minerva Neurosciences : Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business Updates
Feb 28, 2024
Medthority
Minerva Neurosciences: Complete Response Letter from FDA for NDA for roluperidone for the treatment of negative symptoms in patients with schizophrenia
Feb 27, 2024
MarketScreener
Minerva Neurosciences: Minerva Neurosciences Shares Slide on Latest FDA Roluperidone Setback
Feb 23, 2024
Owler
Minerva Neurosciences, Inc.: Minerva Neurosciences's employee count had no change from Dec 2022 to Dec 2023
Feb 22, 2024
Benzinga
Minerva Neurosciences: Minerva Neurosciences: Q4 Earnings Insights
Feb 22, 2024
FinanzNachrichten
Minerva Neurosciences: Minerva Neurosciences, Inc: Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business Updates
Nov 07, 2023
FinanzNachrichten
Minerva Neurosciences: Minerva Neurosciences, Inc: Minerva Neurosciences Reports 2023 Third Quarter Financial Results and Business Updates
Minerva Neurosciences Competitors
1
2
3
4
5
6
7
8
9
10